Cargando…
Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial
Objective: To investigate the efficacy and safety of a novel lower-limb exoskeletal robot, BEAR-H1 (Shenzhen Milebot Robot Technology), in the locomotor function of subacute stroke patients. Methods: The present study was approved by the ethical committee of the First Affiliated Hospital of Nanjing...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419710/ https://www.ncbi.nlm.nih.gov/pubmed/34497506 http://dx.doi.org/10.3389/fnagi.2021.706569 |
_version_ | 1783748807618461696 |
---|---|
author | Li, Yongqiang Fan, Tao Qi, Qi Wang, Jun Qiu, Huaide Zhang, Lingye Wu, Xixi Ye, Jing Chen, Gong Long, Jianjun Wang, Yulong Huang, Guozhi Li, Jianan |
author_facet | Li, Yongqiang Fan, Tao Qi, Qi Wang, Jun Qiu, Huaide Zhang, Lingye Wu, Xixi Ye, Jing Chen, Gong Long, Jianjun Wang, Yulong Huang, Guozhi Li, Jianan |
author_sort | Li, Yongqiang |
collection | PubMed |
description | Objective: To investigate the efficacy and safety of a novel lower-limb exoskeletal robot, BEAR-H1 (Shenzhen Milebot Robot Technology), in the locomotor function of subacute stroke patients. Methods: The present study was approved by the ethical committee of the First Affiliated Hospital of Nanjing Medical University (No. 2019-MD-43), and registration was recorded on the Chinese Clinical Trial Registry with a unique identifier: ChiCTR2100044475. A total of 130 patients within 6 months of stroke were randomly divided into two groups: the robot group and the control group. The control group received routine training for walking, while in the robot group, BEAR-H1 lower-limb exoskeletal robot was used for locomotor training. Both groups received two sessions daily, 5 days a week for 4 weeks consecutively. Each session lasted 30 min. Before treatment, after treatment for 2 weeks, and 4 weeks, the patients were assessed based on the 6-minute walking test (6MWT), functional ambulation scale (FAC), Fugl-Meyer assessment lower-limb subscale (FMA-LE), and Vicon gait analysis. Results: After a 4-week intervention, the results of 6MWT, FMA-LE, FAC, cadence, and gait cycle in the two groups significantly improved (P < 0.05), but there was no significant difference between the two groups (P > 0.05). The ratio of stance phase to that of swing phase, swing phase symmetry ratio (SPSR), and step length symmetry ratio (SLSR) was not significantly improved after 4 weeks of training in both the groups. Further analyses revealed that the robot group exhibited potential benefits, as the point estimates of 6MWT and Δ6MWT (post-pre) at 4 weeks were higher than those in the control group. Additionally, within-group comparison showed that patients in the robot group had a significant improvement in 6MWT earlier than their counterparts in the control group. Conclusions: The rehabilitation robot in this study could improve the locomotor function of stroke patients; however, its effect was no better than conventional locomotor training. |
format | Online Article Text |
id | pubmed-8419710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84197102021-09-07 Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial Li, Yongqiang Fan, Tao Qi, Qi Wang, Jun Qiu, Huaide Zhang, Lingye Wu, Xixi Ye, Jing Chen, Gong Long, Jianjun Wang, Yulong Huang, Guozhi Li, Jianan Front Aging Neurosci Neuroscience Objective: To investigate the efficacy and safety of a novel lower-limb exoskeletal robot, BEAR-H1 (Shenzhen Milebot Robot Technology), in the locomotor function of subacute stroke patients. Methods: The present study was approved by the ethical committee of the First Affiliated Hospital of Nanjing Medical University (No. 2019-MD-43), and registration was recorded on the Chinese Clinical Trial Registry with a unique identifier: ChiCTR2100044475. A total of 130 patients within 6 months of stroke were randomly divided into two groups: the robot group and the control group. The control group received routine training for walking, while in the robot group, BEAR-H1 lower-limb exoskeletal robot was used for locomotor training. Both groups received two sessions daily, 5 days a week for 4 weeks consecutively. Each session lasted 30 min. Before treatment, after treatment for 2 weeks, and 4 weeks, the patients were assessed based on the 6-minute walking test (6MWT), functional ambulation scale (FAC), Fugl-Meyer assessment lower-limb subscale (FMA-LE), and Vicon gait analysis. Results: After a 4-week intervention, the results of 6MWT, FMA-LE, FAC, cadence, and gait cycle in the two groups significantly improved (P < 0.05), but there was no significant difference between the two groups (P > 0.05). The ratio of stance phase to that of swing phase, swing phase symmetry ratio (SPSR), and step length symmetry ratio (SLSR) was not significantly improved after 4 weeks of training in both the groups. Further analyses revealed that the robot group exhibited potential benefits, as the point estimates of 6MWT and Δ6MWT (post-pre) at 4 weeks were higher than those in the control group. Additionally, within-group comparison showed that patients in the robot group had a significant improvement in 6MWT earlier than their counterparts in the control group. Conclusions: The rehabilitation robot in this study could improve the locomotor function of stroke patients; however, its effect was no better than conventional locomotor training. Frontiers Media S.A. 2021-08-23 /pmc/articles/PMC8419710/ /pubmed/34497506 http://dx.doi.org/10.3389/fnagi.2021.706569 Text en Copyright © 2021 Li, Fan, Qi, Wang, Qiu, Zhang, Wu, Ye, Chen, Long, Wang, Huang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Li, Yongqiang Fan, Tao Qi, Qi Wang, Jun Qiu, Huaide Zhang, Lingye Wu, Xixi Ye, Jing Chen, Gong Long, Jianjun Wang, Yulong Huang, Guozhi Li, Jianan Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial |
title | Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial |
title_full | Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial |
title_fullStr | Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial |
title_full_unstemmed | Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial |
title_short | Efficacy of a Novel Exoskeletal Robot for Locomotor Rehabilitation in Stroke Patients: A Multi-center, Non-inferiority, Randomized Controlled Trial |
title_sort | efficacy of a novel exoskeletal robot for locomotor rehabilitation in stroke patients: a multi-center, non-inferiority, randomized controlled trial |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419710/ https://www.ncbi.nlm.nih.gov/pubmed/34497506 http://dx.doi.org/10.3389/fnagi.2021.706569 |
work_keys_str_mv | AT liyongqiang efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial AT fantao efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial AT qiqi efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial AT wangjun efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial AT qiuhuaide efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial AT zhanglingye efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial AT wuxixi efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial AT yejing efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial AT chengong efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial AT longjianjun efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial AT wangyulong efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial AT huangguozhi efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial AT lijianan efficacyofanovelexoskeletalrobotforlocomotorrehabilitationinstrokepatientsamulticenternoninferiorityrandomizedcontrolledtrial |